RWM
BIIB icon

RMG Wealth Management’s Biogen BIIB Stock Holding History

RMG Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04K Hold
5
– – ﹤0.01% 495
2026
Q1 		$990 Sell
5
-80
-94% -$14.7K ﹤0.01% 542
2025
Q4 		$14.8K Buy
85
+5
+6% +$817 ﹤0.01% 225
2025
Q3 		$11.9K Hold
80
– – ﹤0.01% 219
2025
Q2 		$10.1K Buy
+80
New +$9.97K ﹤0.01% 228

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RMG Wealth Management's BIIB Position: Q2 2026 in Review

RMG Wealth Management held its Biogen (BIIB) position steady in Q2 2026 at 5 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #495.

RMG Wealth Management first reported a position in BIIB in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.8K in Q4 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • RMG Wealth Management held 5 shares of Biogen worth $1.04K as of Q2 2026.
  • RMG Wealth Management left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of RMG Wealth Management's portfolio in Q2 2026, its #495 holding.
  • RMG Wealth Management first reported a position in Biogen in Q2 2025 and has held it in 5 quarters since.
  • RMG Wealth Management's Biogen position peaked at $14.8K in Q4 2025.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on RMG Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.